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'the variation and fluctuation of the heart rate in relation to
the mean heart rate have been shown to be a function
of cardiorespiratory physiology . It has been known for
several decades that enhanced vagal tone has a salutary
effect on the electrophysiologic properties of the ventricle
to prevent the emergence of life-threatening ventricular
arrhythmias in certain situations, particularly in postinfarc-
tion and diabetic patients . Hence, heart rate variability may
offer information about sympathetic and parasympathetic
autonomic function and could serve as a measure of risk
stratificatioit for serious cardiac arrhythmias and possible
sudden cardiac death . Notably, continuous changes in the
sympathetic-parasympathetic balance can be reflected in
variations of the sinus rhythm that oscillate around the mean
hem rate . Hence, small adjustments in heart rate are
engendered by cardiovascular control mechanisms . These
mechanisms may involve respiratory movement, gas ex-
chap, chemoreflex, intrathoracic pressure changes, ther-
moregulation and peripheral vascular resistance alterations
that can affect the respiratory centers and, consequently,
cadiovascular centers .
Aninaul Models
In aiiiinal models, enhanced vagal tone has produced an
increase in the ventricular fibrillation threshold . Increased
vagal tone antagonizes the effects of enhanced sympathetic
tone, shortening ventricular refractoriness and heightening,
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in at least one model, baroreceptor response that may
prevent initiation of ventricular fibrillation . These effects
may indicate a link between a low baroreceptor sensitivity
index, as demonstrated with pheitylephrine injections in
humans after myocardial infarction, and a group of patients
at increased risk of dying. Furthermore, in patients with
long-standing diabetes and parasympathetic dysfunction, a
corresponding marked reduction in sinus arrhythmia or
other indexes of vagal tone seems to be associated with an
increased risk of sudden death . Thus, measures of vagal tone
may have prognostic clinical significance .
Measurement of Heart Itate Variability
Heart rate variability has been used to study sympathova-
gal balance (1,2) . Several methods have been proposed to
measure heart rate variability . Two very simple methods
used for many years are 1) the measurement of sinus rate
variability with breathing at a fixed rate of 5 or 6 breaths/min,
and 2) the Valsalva index, which measures the ratio be-
tween the shortest RR intervals during phase 11 and the
maximal RR interval during phase IV . More recently,
analysis of the 24-h Holter ambulatory electrocardiogram
(ECG) has been used to measure heart rate variability (3) .
Methods to analyze heart rate variability employ both time
and frequency domain measurements that quantify period-
icities in the data . Prognostic information to risk stratify
patients for future ventricular arrhythmias or other cardiac
events leading to premature death may be possible by
quantifying heart rate variability, Recently, a detailed
review of the physiology of heart rate variability by van
Ravenswaaij-Arts et al. (4) summarizes the clinical use of
this technology .
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Accuracy
Depending on the method used to evaluate heart rate
variability, several inaccuracies can be introduced . It is very
important that artifacts or premature complexes in the
recording not be included in the analysis or there can be
possible miscounting of heart rate due to sensing of the T
wave. Miscounting of heart rate can add inaccuracy to the
system .
Cost
Several Holter systems already employ heart rate vari-
ability in the analysis algorithm (3) . The cost of this proce-
dure does not appear to be excessive at the present time . As
with other new diagnostic methods, there could be a hidden
cost of heart rate variability testing if chi aica,i decisions are
based on its results and lead to further diagnostic tests or
therapy .
Safety
The technique appears to be safe. It is noninvasive and
free of electrical hazards .
Comparison Mth Alternative Technologies
for Risk Stratification
Post.myocardial infarction patients. Depending on the con-
dition being studied, several alternative methods are available
for risk stratification . In patients after myocardial infarction,
assessment of left ventricular function, measurements of
baroreceptor sensitivity, quantification of ventricular arrhyfti-
mias during 24-h Holler ambulatory ECG recording, signal-
averaged ECG studies and electrophysiologic testing have all
been used to determine risk for subsequent sudden death .
Exercise testing and other measures to evaluate ischemia are
also important in this patient group . Kleiger et al . (5) recently
reported a weak correlation between time and frequency
domain measures of heart rate variability and more traditional
risk predictors . When Farrell et al . (3) analyzed risk stratifica-
tion for arrhythmic events in postmyocardial ii,arction patients
utilizing heart rate variability, ambulatory ECG variables,
signal-averaged ECG and left ventricular function ; they found
that impaired heart rate variability was most predictive of
future arrhythmic events . However, when impaired heart rate
variability was combined with the presence of late potentials on
the signal-averaged ECG, the sensitivity was only 58% .
Baroreflex sensitivity assessed with phenylephrine injection
weakly correlated with heart rate variability .
Patients with congestive heart failure . These patients are
also clearly at increased risk for sudden death . Risk stratifi-
cation has included many of the same tests used for post-
myocardial infarction patients, and heart rate variability has
also been shown to be decreased in this condition . In one
investigation by Kienzle et al. (6), measures of heart rate
I
DROFUS ET AL
ACC P05
!TEON STAIEMEAT
949
variability were not significantly related to left ventricular
ejection fraction, although some were weakly correlated
with cardiac output
. There were suggestions from this study
that a stronger correlation occurred with measurements of
sympathoexcitation. Few data are available regarding risk
stratification using heart rate variability in these patients .
Unanswered Questions
Two major questions concerning heart rate variability
remain to be clarified . First, many methods to measure heart
rate variability have been reported, and it is very difficult to
conclude which one is most appropriate for establishing
normal values and for particular patient subgroups . In a
recent study, Bigger et al . (7) evaluated 12 separate mea-
surements of time and frequency domain analysis . There is a
need to standardize the measurement of heart rate variability
and to quantify normal values under various circumstances,
including paticut age and gender . Second, the sensitivity,
specificity and predictive accuracy of this test require much
more prospective investigation . Correlations of this'zest with
other risk stratification measurements will be necessary to
evaluate its independent predictive value . The preliminary
data available do not allow for definitive conclusions .
Furthermore, the value of heart rate variability or any
other risk stratification test in patients who undergo revas-
cularization of infarcting myocardium requires assessment .
It appears that mortality after myocardial infarction is de-
creasing with the new and aggressive therapeutic methods
being used, and heart rate variability will have to be evalu-
ated in this setting . Similar evaluations need to be performed
in other pathophysiologic states such as congestive heart
failure .
Future Research
Prospective multicenter studies should be undertaken to
determine the sensitivity, specificity and predictive accuracy
of heart rate variability in various situations, particularly in
patients after acute myocardial infarction (8-12) and in those
with congestive heart failure (2,6,13,14) . It will be necessary
to assess whether heart rate variability testing alone or in
combination with other variables is an important predictor of
sudden cardiac death (8,15-17) both in survivors of cardiac
arrest (8,15,16) and in patients with chronic heart disease
who appear to be at risk for cardiac arrest . Recent studies by
Dougherty and Burr (15) in survivors of sudden cardiac
arrest demonstrated that 1-year mortality in the survivor
group was inversely related to several variables, including
age, standard deviation of all RR intervals and low frequency
spectral power. Determination of normal values and of
optimal time and frequency domain measurements to be
used should be made with the use of appropriate control
groups
. It is important to evaluate patients with similar ages
and disease states because these variables can affect heart
rate variability
. Normal values in a relatively small series
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TablIc 1 . Twenty-Four-Hour Average Heart Rate Variability
*p z 0.001, tp < 0 .01, comparing survivors of cardiac arrest and control
patients, Data am Klee, with NimUsion; from Huikuri et al . (171 .
were reported by Huikuri et al . (17) (Table 1 ) . Further
studies should be stratified for age and t,
tender and should
utilize both fast Fourier analysis and autoregressive
meth-
ods.
Status
Heart rate variability is a very interesting method of
evaluating parasympathetic and sympathetic effects on heart
rate in humans, and preliminary data suggest it could be-
come an important prognostic tool . There are substantial
unanswered questions that preclude heart rate variability
from being a standard clinical test at present ; until more data
are known it should be considered as a clinical investigation .
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Survivors of Cardiac
Arrest
(1 = 22)
Control Patients
(n = 22)
SD of RR intervals (ms) 29 :t 10 51 ± 15*
High frequency spectral area 13 ± 7 2e ± 4t
(ms
1
.
x 10)
Low frequency spectral area 14 ± 13 22_12
(ms 2 x 10)
Ratio between low and high
frequency areas
1 .2 ± 0.9 0.9 ± 0.3
